Skip to main content
Journal cover image

Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment.

Publication ,  Journal Article
Rapaport, R; Rose, SR; Freemark, M
Published in: J Pediatr
August 2001

Duke Scholars

Published In

J Pediatr

DOI

ISSN

0022-3476

Publication Date

August 2001

Volume

139

Issue

2

Start / End Page

182 / 188

Location

United States

Related Subject Headings

  • Thyroxine
  • Thyrotropin
  • Thyroid Gland
  • Risk Factors
  • Pediatrics
  • Infant, Premature
  • Infant, Newborn
  • Hypothyroidism
  • Humans
  • 1114 Paediatrics and Reproductive Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rapaport, R., Rose, S. R., & Freemark, M. (2001). Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr, 139(2), 182–188. https://doi.org/10.1067/mpd.2001.116934
Rapaport, R., S. R. Rose, and M. Freemark. “Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment.J Pediatr 139, no. 2 (August 2001): 182–88. https://doi.org/10.1067/mpd.2001.116934.
Rapaport R, Rose SR, Freemark M. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr. 2001 Aug;139(2):182–8.
Rapaport, R., et al. “Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment.J Pediatr, vol. 139, no. 2, Aug. 2001, pp. 182–88. Pubmed, doi:10.1067/mpd.2001.116934.
Rapaport R, Rose SR, Freemark M. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr. 2001 Aug;139(2):182–188.
Journal cover image

Published In

J Pediatr

DOI

ISSN

0022-3476

Publication Date

August 2001

Volume

139

Issue

2

Start / End Page

182 / 188

Location

United States

Related Subject Headings

  • Thyroxine
  • Thyrotropin
  • Thyroid Gland
  • Risk Factors
  • Pediatrics
  • Infant, Premature
  • Infant, Newborn
  • Hypothyroidism
  • Humans
  • 1114 Paediatrics and Reproductive Medicine